Drug-eluting stents have undergone continuous technical improvements in scaffold materials, strut design, and polymer coatings, which impact cardiovascular outcomes in percutaneous revascularization.
This review highlights the technical progress of drug-eluting stents and how variations in stent platforms, such as material and coating, impact clinical outcomes.
Drug-eluting stents (DES) demonstrated superior efficacy when compared to bare metal stents and plain-old balloon angioplasty and are nowadays used in almost all percutaneous revascularization procedures. The design of the stent platforms is constantly improving to maximize its efficacy and safety. Constant development of DES includes adoption of new materials used for scaffold production, new design types, improved overexpansion abilities, new polymers coating and, finally, improved antiproliferative agents. Especially nowadays, with the immense number of available DES platforms, it is crucial to understand how different aspects of stents impact the effect of their implantation, as subtle differences between various stent platforms could impact the most important issue-clinical outcomes. This review discusses the current status of coronary stents and the impact of stent material, strut design and coating techniques on cardiovascular outcomes.
Koźlik et al. (Thu,) conducted a review in Coronary artery disease. Drug-eluting stents was evaluated. Drug-eluting stents have undergone continuous technical improvements in scaffold materials, strut design, and polymer coatings, which impact cardiovascular outcomes in percutaneous revascularization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: